Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Organigram Hlds Inc (NQ: OGI )

1.850 +0.010 (+0.54%)
Streaming Delayed Price Updated: 4:00 PM EDT, Aug 30, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 205,364
Open 1.860
Bid (Size) 1.840 (22)
Ask (Size) 1.850 (97)
Prev. Close 1.840
Today's Range 1.830 - 1.889
52wk Range 0.9702 - 2.910
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Top Seller Of Pharmaceutical Cannabis Outside US Grew By Double-Digits, Focuses On Germany
Via Benzinga
Topics Cannabis
Exposures Cannabis
Largest Cannabis Stocks Are Down +10% In Last Two Days: Here's Why
The American Cannabis MSO Portfolio is DOWN 13.2% in the past 2 days and is now DOWN 18.4% MTD (and DOWN 5.9% YTD). 
Via Talk Markets
Topics Cannabis
Exposures Cannabis

Performance

YTD
+41.76%
+41.76%
1 Month
+17.83%
+17.83%
3 Month
+11.78%
+11.78%
6 Month
-8.42%
-8.42%
1 Year
+20.13%
+20.13%

More News

Read More
Marijuana Stock Movers For August 27, 2024
Via Benzinga
Topics Cannabis
Exposures Cannabis
Key Cannabis Leaders Gather For Networking At Benzinga's Fall 2024 Conference: The Last Big Event Before The Election
Via Benzinga
Topics Cannabis
Exposures Cannabis
Why Is Organigram (OGI) Stock Up 25% Today?
Via InvestorPlace
Cannabis Stock Gainers And Losers From August 23, 2024
Via Benzinga
Topics Cannabis
Exposures Cannabis
CEO Shake-Ups At Canopy, Curaleaf And Recent Top Exec And Board Changes In Cannabis And Psychedelics
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis Company, Organigram, Reports An Impressive Q3 Turnaround
Via Talk Markets
Topics Cannabis
Exposures Cannabis
Cannabis Stock Movers For August 13, 2024
Via Benzinga
Topics Cannabis
Exposures Cannabis
Organigram (OGI) Q3 2024 Earnings Call Transcript
Via The Motley Fool
Topics Earnings
Exposures Financial
OGI Stock Earnings: OrganiGram Holdings Beats EPS, Beats Revenue for Q3 2024
Via InvestorPlace
Organigram Reports 25% YoY Increase In Q3 Net Revenue, Significant Improvement In Adjusted EBITDA
Via Benzinga
Topics Cannabis
Exposures Cannabis
Organigram Reports Third Quarter Fiscal 2024 Results
From Organigram Holdings Inc.
Via Business Wire
Cannabis Stock Movers For August 8, 2024
Via Benzinga
Topics Cannabis
Exposures Cannabis
Organigram's Promising Results From Nanoemulsion Technology Study To Improve Cannabis Edibles
Via Benzinga
Topics Cannabis
Exposures Cannabis
Organigram Product Development Collaboration Completes Landmark Clinical Study on Nanoemulsion Technology
From Organigram Holdings Inc.
Via Business Wire
Marijuana Stock Movers For August 6, 2024
Via Benzinga
Topics Cannabis
Exposures Cannabis
IM Cannabis, Organigram And Other Hot Cannabis Stocks Soon To Report Earnings, What Investors Need To Know Now
Via Benzinga
Topics Cannabis
Exposures Cannabis
Organigram to Report Third Quarter Fiscal 2024 Results on August 13, 2024
From Organigram Holdings Inc.
Via Business Wire
The 3 Best Cannabis Stocks to Buy in August 2024
Via InvestorPlace
Topics Cannabis
Exposures Cannabis
Marijuana Stock Movers For August 2, 2024
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis Stock Movers For July 30, 2024
Via Benzinga
Topics Cannabis
Exposures Cannabis
Organigram Announces Appointment of Craig Harris to Board of Directors
From Organigram Holdings Inc.
Via Business Wire
Canadian Cannabis LPs Out-Performed American MSOs Again This Week
Via Talk Markets
Topics Cannabis
Exposures Cannabis
Organigram to Bolster Auto-Flower and Rare Cannabinoid Portfolio with Partial Third Tranche Investment of US $1M into Phylos
From Organigram Holdings Inc.
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.